Mustafa Deryal
-
- Breast Cancer Treatment Studies 4
-
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 3
- HER2/EGFR in Cancer Research 2
-
- Nutrition, Genetics, and Disease 1
-
- RNA modifications and cancer 1
-
- Ovarian cancer diagnosis and treatment 3
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Werner SchmidtUlrich MahlknechtMei Fang OngMark LipphardtF. DegenhardtPeter HillemannsKubilay ErtanSebastian Wojcinski
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (2 papers)Annals of Oncology (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Mustafa Deryal
11 papers receiving 66 citations
Peers
Comparison fields: 5 of 34
- Cancer Research 19
- Oncology 23
- Genetics 14
- Molecular Biology 32
- Endocrine and Autonomic Systems 2
Countries citing papers authored by Mustafa Deryal
This map shows the geographic impact of Mustafa Deryal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Deryal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Deryal more than expected).
Fields of papers citing papers by Mustafa Deryal
This network shows the impact of papers produced by Mustafa Deryal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Deryal. The network helps show where Mustafa Deryal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mustafa Deryal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 0 | |
| 9 | 2013 | 29 | |
| 10 | ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population. | 2013 | 14 |
| 11 | 2013 | 1 | |
| 12 | 2012 | 8 |
About Mustafa Deryal
Mustafa Deryal is a scholar working on Reproductive Medicine, Oncology and Cancer Research, having authored 12 papers that have together received 66 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (3 papers), Advanced Breast Cancer Therapies (2 papers), HER2/EGFR in Cancer Research (2 papers), Nutrition, Genetics, and Disease (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (19 citations), Oncology (23 citations) and Genetics (14 citations). Mustafa Deryal has collaborated with scholars based in Germany and United States. Frequent co-authors include Werner Schmidt, Ulrich Mahlknecht, Mei Fang Ong, Mark Lipphardt, F. Degenhardt, Peter Hillemanns, Kubilay Ertan, Sebastian Wojcinski, Barbara Schmalfeldt and Michael P. Lux. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.